Agios Pharmaceuticals
AGIO
AGIO
156 hedge funds and large institutions have $2.39B invested in Agios Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
4% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 25
3% less funds holding
Funds holding: 161 → 156 (-5)
20% less call options, than puts
Call options by funds: $14.3M | Put options by funds: $17.9M
Holders
156
Holding in Top 10
7
Calls
$14.3M
Puts
$17.9M
Top Buyers
| 1 | +$125M | |
| 2 | +$33.4M | |
| 3 | +$25.1M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$13.3M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.7M |
Top Sellers
| 1 | -$12M | |
| 2 | -$11.1M | |
| 3 | -$6.51M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.23M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.19M |